About 100 reports

  • DIGESTIVE REMEDIES IN THE US - CATEGORY ANALYSIS

Stress can cause and exacerbate numerous digestive disorders, including nausea, indigestion and heartburn, as well as general gastrointestinal upset.

  • Allergy Drug
  • Gastrointestinal Drug
  • OTC
  • United States
  • Demand
  • TRENDS

In addition, stressful and fast-paced lifestyles, with tight schedules and traffic jams, impact the digestive system, causing tension, which is reflected in gastrointestinal discomfort.

  • Gastrointestinal Drug
  • OTC
  • Colombia
  • Demand
  • Tecnoquímicas SA
  • MICROCAM NAVI - UPPER GASTROINTESTINAL DISORDERS - PRODUCT STATUS
  • MICROCAM NAVI - UPPER GASTROINTESTINAL DISORDERS - PRODUCT DESCRIPTION
  • Clinical Trial
  • Gastrointestinal Drug
  • United States
  • Company
  • GlobalData's company
  • Clinical Trial profile. 920 Trial Title
  • Clinical Trial profile. 842 Trial Title

ESOPHAGITIS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017* CLINICAL TRIALS BY E## COUNTRIES: PROPORTION OF ESOPHAGITIS TO GASTROINTESTINAL CLINICAL TRIALS AMONG THE E## (BRAZIL, RUSSIA, INDIA, CHINA, MEXICO, TURKEY AND INDONESIA) COUNTRIES, BRAZIL HAVE THE HIGHEST PROPORTI

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS
  • Gastrointestinal Drug
  • Opioid
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 846 Trial Title
  • Target

PROPORTION OF ESOPHAGEAL DISEASES TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF ESOPHAGEAL DISEASES TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* IN TOTAL THERE WERE ## CLINICAL TRIALS CONDUCTED ON ESOPHAGEAL DISEASES, AS OF AUGUST 2017

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Clinical Trial profile. 35 Trial Title
  • Clinical Trial profile. 203 Trial Title

PROPORTION OF EMESIS (VOMITING) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF EMESIS (VOMITING) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF EMESIS (VOMITING) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%),

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Opioid-Induced Constipation (OIC) - Pipeline by Theravance Biopharma Inc, H2 2017
  • Opioid-Induced Constipation (OIC) - Pipeline by Sucampo Pharmaceuticals Inc, H2 2017

These medicines affect the gastrointestinal tract in a variety of ways.

  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 99 Trial Title
  • Clinical Trial profile. 177 Trial Title

PROPORTION OF DUODENAL ULCER TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF DUODENAL ULCER TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* In total there were ## clinical trials conducted on Duodenal Ulcer, as of July 2017 in G## Countries, o

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Braintree Laboratories Inc.
  • Official Title
  • Official Title

PROPORTION OF DYSPEPSIA TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of July 2017 PROPORTION OF DYSPEPSIA TO

  • Clinical Trial
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Yt Blood Group
  • Clinical Trial profile. 17 Trial Title
  • Target

PROPORTION OF BARRETTS ESOPHAGUS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF BARRETTS ESOPHAGUS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* AS OF APRIL 2017, THERE WERE ## CLINICAL TRIALS IN PHASE II, OF WHICH THREE CLINICAL TRIALS WE

  • Gastrointestinal Drug
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • Official Title

PROPORTION OF FUNCTIONAL (NON ULCER) DYSPEPSIA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FUNCTIONAL (NON ULCER) DYSPEPSIA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FUNCTIONAL (NON ULCER) DYSPEPSIA TO

  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Yt Blood Group
  • FECAL INCONTINENCE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*
  • Clinical Trial profile. 38 Trial Title

PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • RDD Pharma
  • Clinical Trial profile. 5 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

PROPORTION OF CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* In total there were ## clinical trials condu

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Takeda Pharmaceutical Company Limited
  • Target
  • Clinical Trial profile. 21 Trial Title
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Bayer AG
  • Clinical Trial profile. 301 Trial Title
  • Target

Upper gastrointestinal endoscopy will be performed prior to drug treatment, and at the end of the ##-day study period.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC
  • 05/24/2016: EVOKE PHARMA PRESENTS DATA FROM SUCCESSFUL THOROUGH ECG (TQT) STUDY OF EVK-001 AT DIGESTIVE DISEASE WEEK 2016

Evoke Pharma Inc (Evoke Pharma) is a specialty pharmaceutical company that develops drugs to treat gastrointestinal diseases.

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • United States
  • Evoke Pharma, Inc.
  • SCHNELL BIOPHARMA COMPLETES ISSUE OF EIGHTH UNSECURED BONDS DUE 2014 FOR US$14.5 MILLION
  • SCHNELL BIOPHARMA COMPLETES ISSUE OF NINTH UNSECURED BONDS DUE 2014 FOR US$8.8 MILLION

Its products portfolio includes antibiotics, infusions, containing amino acid, vitamin and hepatic protect infusions; gastrointestinal agents, comprising of digestives and antiulcerants.

  • Gastrointestinal Drug
  • South Korea
  • Corporate Finance
  • M&A
  • Biopharmaceuticals Inc.
  • Clinical Trials by G7 Countries: Proportion of Constipation to Gastrointestinal Clinical Trials
  • Proportion of Constipation to Gastrointestinal Clinical Trials, E7 Countries (%), 2016*
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials
  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative
  • PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World
  • Product Initiative
  • VENTURE FINANCING
  • Deal Type

Seeto has published several publications in peer-reviewed journals, including publications focused on his work in gastrointestinal research.

  • Gastrointestinal Drug
  • United States
  • Company
  • Company Operations
  • Ardelyx, Inc.
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2016*
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • DIARRHEA - PIPELINE BY RXBIO INC, H1 2017
  • DIARRHEA - PIPELINE BY REDHILL BIOPHARMA LTD, H1 2017

Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • World
  • Product Initiative
  • NARONAPRIDE - DRUG PROFILE
  • DA-6886 - DRUG PROFILE

These agents also stimulate motility throughout the gastrointestinal tract.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Clinical Trial profile. 121 Trial Title
  • Clinical Trial profile. 46 Trial Title

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Hospital
  • World
  • Product Initiative
  • Clinical Trial profile. 64 Trial Title
  • Clinical Trial profile. 568 Trial Title
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Clinical Trial profile. 19 Trial Title
  • Clinical Trial profile. 13 Trial Title

Top Countries Contributing to Clinical Trials in Middle East and Africa Acidity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* Clinical Trials by G## Countries: Proportion of Acidity to Gastrointestinal Clinical Trials Among the G## (United States, United Kingdom,

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Bayer AG
  • PARTNERSHIPS
  • ACQUISITION

Synergy Pharmaceuticals Inc (Synergy Pharma) develops therapies for gastrointestinal (GI) diseases.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synergy Pharmaceuticals, Inc.